title: Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice.
abstract: A clear link exists between iron deficiency (ID) and nigrostriatal dopamine malfunction. This link appears to play an important role in at least restless legs syndrome (RLS) if not several other neurological diseases. Yet, the underlying mechanisms remain unclear. The effects of ID on gene expression in the brain have not been studied extensively. Here, to better understand how exactly ID alters dopamine functioning, we investigated the effects of ID on gene expression in the brain, seeking to identify any potential transcription-based mechanisms. We used six strains of recombinant inbred mice (BXD type) known to differ in susceptibility to ID in the brain. Upon weaning, we subjected mice from each strain to either an iron-deficient or iron-adequate diet. After 100 days of dietary treatment, we measured the effects of ID on gene expression in the ventral midbrain, a region containing the substantia nigra. The substantia nigra is the base of the nigrostriatal dopamine pathway and a region particularly affected by iron loss in RLS. We screened for ID-induced changes in expression, including changes in that of both iron-regulating and dopamine-related genes. Results revealed a number of expression changes occurring in ID, with large strain-dependent differences in the genes involved and number of expression changes occurring. In terms of dopamine-related genes, results revealed ID-induced expression changes in three genes with direct ties to nigrostriatal dopamine functioning, two of which have never before been implicated in an iron-dopamine pathway. These were stromal cell-derived factor 1 (Cxcl12, or SDF-1), a ferritin regulator and potent dopamine neuromodulator, and hemoglobin, beta adult chain 1 (Hbb-b1), a gene recently shown to play a functional role in dopaminergic neurons. The extent of up-regulation of these genes varied by strain. This work not only demonstrates a wide genetic variation in the transcriptional response to ID in the brain, but also reveals two novel biochemical pathways by which iron may potentially alter dopamine function.
authors.affiliation: Neuroscience Institute, The Pennsylvania State University, University Park, PA, USA.
authors.forename: L C
authors.initials: LC
authors.lastname: Jellen
authors.forename: L
authors.initials: L
authors.lastname: Lu
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: E L
authors.initials: EL
authors.lastname: Unger
authors.forename: C J
authors.initials: CJ
authors.lastname: Earley
authors.forename: R P
authors.initials: RP
authors.lastname: Allen
authors.forename: R W
authors.initials: RW
authors.lastname: Williams
authors.forename: B C
authors.initials: BC
authors.lastname: Jones
mesh_terms: D000818:Animals; D054377:Chemokine CXCL12 / Q000235:genetics* / Q000378:metabolism; D004298:Dopamine / Q000235:genetics* / Q000378:metabolism; D006454:Hemoglobins / Q000235:genetics* / Q000378:metabolism; D000090463:Iron Deficiencies; D008636:Mesencephalon / Q000378:metabolism*; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D060888:Real-Time Polymerase Chain Reaction; D012148:Restless Legs Syndrome / Q000235:genetics / Q000378:metabolism; D059467:Transcriptome
chemical_list: D054377:Chemokine CXCL12; C515256:Cxcl12 protein, mouse; D006454:Hemoglobins; C020622:hemoglobin B; D004298:Dopamine
keywords: ANCOVA; Alas2; BXD; Cxcl12; Drd2; FDR; FHC; GSEA; Gene Set Enrichment Analysis; Hbb-b1; ID; LR ratio; RLS; RT-PCR; Real-Time Polymerase Chain Reaction; Rsad2; TH; Tfrc; VMB; aminolevulinic acid synthase 2; analysis of covariance; dopamine receptor 2; false discovery rate; ferritin heavy-chain; iron deficiency; log(2) ratio; radical S-adenosyl methionine domain containing 2; recombinant inbred strains; restless legs syndrome; transferrin receptor; tyrosine hydroxylase; ventral midbrain
references.citation: Brain. 2009 Sep;132(Pt 9):2403-12
references.pmid: 19467991
references.citation: J Biol Chem. 2006 Dec 8;281(49):37616-27
references.pmid: 17056593
references.citation: Am J Physiol Regul Integr Comp Physiol. 2012 Jun;302(11):R1282-96
references.pmid: 22461179
references.citation: BMC Bioinformatics. 2008 Dec 04;9:520
references.pmid: 19055840
references.citation: J Nutr. 2000 Nov;130(11):2831-7
references.pmid: 11053528
references.citation: Nutr Rev. 2011 Nov;69 Suppl 1:S43-8
references.pmid: 22043882
references.citation: J Neurochem. 2007 Aug;102(4):1175-83
references.pmid: 17509088
references.citation: Neurology. 2008 Sep 16;71(12):911-6
references.pmid: 18794493
references.citation: PLoS Biol. 2009 Jun 9;7(6):e1000123
references.pmid: 19513100
references.citation: Behav Brain Res. 2002 Aug 21;134(1-2):517-24
references.pmid: 12191838
references.citation: J Neurochem. 2006 Mar;96(6):1540-50
references.pmid: 16476083
references.citation: J Nutr. 2007 Jan;137(1):118-24
references.pmid: 17182811
references.citation: Nutr Neurosci. 2005 Feb;8(1):31-8
references.pmid: 15909765
references.citation: Am J Hematol. 2013 Apr;88(4):261-4
references.pmid: 23494945
references.citation: Glia. 2009 Apr 1;57(5):467-78
references.pmid: 18837051
references.citation: Alcohol Clin Exp Res. 2003 Jan;27(1):1-11
references.pmid: 12543998
references.citation: Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):409-18
references.pmid: 11509198
references.citation: Cancer Cell Int. 2010 Aug 19;10:28
references.pmid: 20723262
references.citation: Sleep Med. 2009 Feb;10(2):206-11
references.pmid: 18280205
references.citation: Biochimie. 2009 Oct;91(10):1255-9
references.pmid: 19393285
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15454-9
references.pmid: 19717439
references.citation: Dev Neurosci. 2003 Sep-Oct;25(5):308-15
references.pmid: 14614257
references.citation: Neuroscience. 2009 Jun 16;161(1):13-22
references.pmid: 19303923
references.citation: Nature. 2002 Jun 13;417(6890):758-63
references.pmid: 12066189
references.citation: Dev Neurosci. 2010 Aug;32(3):238-48
references.pmid: 20689287
references.citation: Eur J Neurosci. 2008 Sep;28(5):862-70
references.pmid: 18671738
references.citation: Sleep Med. 2006 Aug;7(5):458-61
references.pmid: 16740411
references.citation: J Neural Transm Suppl. 2006;(71):173-96
references.pmid: 17447428
references.citation: Pharmacogenetics. 1999 Oct;9(5):607-17
references.pmid: 10591541
references.citation: J Nutr. 2011 Apr 1;141(4):740S-746S
references.pmid: 21346104
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
references.pmid: 16199517
references.citation: Brain Res. 2008 Oct 27;1237:75-83
references.pmid: 18723004
references.citation: Sleep Med. 2011 Jun;12(6):614-9
references.pmid: 21570342
references.citation: Hippocampus. 2007;17(8):679-91
references.pmid: 17546681
references.citation: Neurogenetics. 2012 May;13(2):147-57
references.pmid: 22457016
references.citation: Biochim Biophys Acta. 2009 Jul;1790(7):606-14
references.pmid: 18778755
references.citation: J Neurochem. 2008 Jul;106(1):205-15
references.pmid: 18363828
references.citation: Neurology. 2003 Aug 12;61(3):304-9
references.pmid: 12913188
references.citation: J Nutr. 2003 May;133(5 Suppl 1):1468S-72S
references.pmid: 12730445
references.citation: Antioxid Redox Signal. 2014 Mar 10;20(8):1324-63
references.pmid: 23815406
references.citation: Biochem J. 2011 Mar 15;434(3):365-81
references.pmid: 21348856
references.citation: J Mol Endocrinol. 2007 Mar;38(3):365-76
references.pmid: 17339399
references.citation: Behav Brain Res. 2006 Aug 10;171(2):261-70
references.pmid: 16713640
references.citation: Pharmacol Biochem Behav. 1994 Jul;48(3):621-4
references.pmid: 7524105
references.citation: BMC Mol Biol. 2006 Jan 31;7:3
references.pmid: 16448564
references.citation: Mov Disord. 2008 Jun 15;23(8):1184-7
references.pmid: 18442125